Hideki Takeda
Vermögen: 868 227 $ am 30.06.2026
Vermögen: 868 227 $ am 30.06.2026
Hideki Takeda is the founder of Scent Science International, Inc. He is currently an Independent Outside Director at Modalis Therapeutics Corp., a Representative Director at Medical Patent Research, Inc., an Outside Director at Ctex Co. Ltd., and a Director at Liid Pharmaceuticals, Inc. He received his undergraduate and graduate degrees from Osaka University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PRISM BioLab Co., Ltd.
PRISM BioLab Co., Ltd. BiotechnologyHealth Technology Provides drug discovery and development services using proprietary platform technology 2,53 % | 31.03.2026 | 935.000 ( 2,53 % ) | 828 429 $ | 30.06.2026 |
| 31.12.2025 | 196.000 ( 0,2 % ) | 39 798 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MODALIS THERAPEUTICS CORPORATION | Direktor/Vorstandsmitglied | 01.01.2016 |
Medical Patent Research, Inc. | Direktor/Vorstandsmitglied | 01.01.2009 |
Ctex Co. Ltd. | Direktor/Vorstandsmitglied | 01.02.2018 |
Scent Science International, Inc.
Scent Science International, Inc. Industrial ConglomeratesProducer Manufacturing Develops animal repellant | Gründer | 23.07.2010 |
Liid Pharmaceuticals, Inc. | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Osaka University
Osaka University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scent Science International, Inc.
Scent Science International, Inc. Industrial ConglomeratesProducer Manufacturing Develops animal repellant | Producer Manufacturing |
Modalis Therapeutics Corp.
Modalis Therapeutics Corp. BiotechnologyHealth Technology Develops transformative therapeutics for diseases which are caused by malfunctioning of genes | Health Technology |
Medical Patent Research, Inc. | |
Ctex Co. Ltd. | |
Liid Pharmaceuticals, Inc. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen